EPAM vs PPCB · P/E 14, rev $4.73B vs P/E 0.0, $3.9M cap
EPAM Systems Inc (EPAM) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
PPCB does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the EPAM and PPCB stock pages for the full models.
Not investment advice.